FDA clearance is a critical regulatory milestone that can significantly impact a company's product marketability and consumer trust. For Masimo, this clearance not only expands its product line but also enters it into the consumer health sector, potentially increasing sales and market share. Given the importance of FDA approval in the healthcare and consumer product sectors, this development is likely to be viewed positively by investors and could lead to a short-term uptick in Masimo's stock price.